A Study in Patients With Major Depressive Disorder

Clinical trial NCT03642964 · UNKNOWN

Trial details

NCT number: NCT03642964
Sponsor: Chase Therapeutics Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder (MDD)

Start date: 2018-09-10
Primary completion: 2025-12-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.